Browse the evidence

While a protein-polyphenol beverage accelerates early functional adaptations and increases type II fiber hypertrophy, it does not further increase peak isometric torque, overall muscle function, or total quadriceps muscle volume compared to placebo in the later stages of resistance training (sessions 10-30).

Don't expect this specific supplement to make you bigger or stronger than standard protein in the long run. The early boost in function and fiber size is nice, but for overall muscle volume and peak strength after the first month, it offers no advantage over a placebo or standard protein. You can likely stop the specialized polyphenol supplements after the initial adaptation phase.

Polygenic scores derived from 59 SNPs associated with central adiposity predict a smaller reduction in waist circumference after one year of lifestyle intervention, though the effect size is too small to be clinically significant.

Your genes might make it slightly harder to lose belly fat compared to someone else with different genetics, but the difference is less than a centimeter. This is too small to matter for your health goals. Focus on the lifestyle intervention (diet and exercise) as it provides a much larger benefit than any genetic disadvantage.

Short-term (2-week) crossover metabolic ward trials without washout periods are invalid for determining chronic macronutrient effects on energy intake and body fat due to massive, differential carry-over effects from physiologic adaptation.

Do not rely on short-term (under 4-6 weeks) diet studies to predict long-term weight loss outcomes. The body's metabolic adaptation to macronutrient changes (like ketosis or insulin shifts) takes weeks to months. Short trials often measure transient adaptation rather than chronic effects, leading to misleading conclusions about which diet is superior for fat loss.

Accelerometer-derived summary metrics (MIMS-unit, AAI, MAD, ENMO) derived from raw data provide greater comparability across different device manufacturers and models than traditional proprietary activity counts.

If you are a researcher, stop relying on proprietary 'counts' to compare studies. Use open-source raw data algorithms (like MIMS-unit or AAI) to ensure your findings are comparable across different device brands. If you are a consumer, understand that 'steps' or 'activity scores' from different brands are not mathematically equivalent, even if they look similar.

Cardiac diastolic function, specifically the E/e' ratio and Left Atrial Volume Index (LAVI), significantly moderates the reduction in relative peak oxygen uptake in Type 2 Diabetes patients.

For T2D patients, standard cardiac checks might miss the root cause of exercise intolerance. If you struggle with exercise despite normal ejection fraction, ask about diastolic function (E/e' ratio). Addressing this through specific training (like high-intensity interval training, as suggested by the authors) may be more effective than generic advice.

Bariatric surgery, specifically Roux-en-Y gastric bypass (RYGB), is a highly effective treatment for severe obesity, providing rapid and durable weight loss, though it carries risks of adverse events and nutritional deficiencies.

For individuals with severe obesity (BMI >40 or >35 with comorbidities), bariatric surgery like RYGB is a highly effective, durable treatment. It is not a cosmetic procedure but a medical intervention for severe disease. Patients must be prepared for lifelong nutritional monitoring to prevent deficiencies.

Altering shoulder position (flexed vs. extended) during elbow flexion resistance training does not influence regional hypertrophy or maximum strength gains when resistance profiles are matched.

If you are doing biceps curls, it does not matter whether you sit on a preacher bench (shoulder flexed) or lie back on an incline bench (shoulder extended), as long as you are lifting heavy enough to fail around 8-12 reps. Both positions will build muscle and strength equally well. Do not waste time switching exercises to 'target' the long head; just pick one and focus on adding weight over time.

Total energy expenditure (TEE) and activity energy expenditure (AEE) exhibit greater male variability (GMV) that peaks in young adulthood and declines in old age, whereas basal energy expenditure (BEE) and standard morphometrics (height, fat-free mass) do not follow this specific life-course pattern.

Energy expenditure is not a fixed number but a variable trait that differs significantly between individuals, especially men during their reproductive years. This variability is driven by complex interactions of activity, muscle mass, and other traits, not just basal metabolic rate or height. For health planning, individualized assessment of energy needs is more critical than relying on population averages, particularly for young adult males.

There are significant research gaps regarding the effectiveness of nutritional interventions for underrepresented populations, specifically women, older adults, and Asian populations.

Be aware that most research on muscle hypertrophy interventions focuses on men and Western populations. If you are a woman, older adult, or from an Asian background, the optimal nutritional strategy may differ, and you should consult a professional for personalized guidance.

Obesity is a primary chronic disease driven largely by genetic predisposition, amplified by caloric intake and decreased energy expenditure, requiring recognition as a disease for proper insurance coverage and management.

Stop blaming yourself or your patients for obesity. It is a primary disease with strong genetic components. This recognition is the first step to getting proper insurance coverage and medical treatment, not just lifestyle advice.

Using external momentum (cheat repetitions) during single-joint upper body resistance training produces muscle hypertrophy equivalent to strict technique, despite generating significantly higher volume load.

If you are doing single-joint exercises like bicep curls or tricep pushdowns, you don't need to be rigid about 'strict' form to maximize muscle growth. Using 'cheat' reps (adding momentum) allows you to lift more total volume, which resulted in the same muscle growth as strict reps in this study. However, be cautious of joint stress, especially in your back and hips, as momentum can increase injury risk. Use this technique strategically, perhaps at the end of a set, rather than for every rep, to balance gains with safety.

In older adults, visceral fat levels significantly decrease over two years, while body weight, muscle mass, and total body fat percentage do not change significantly.

As you age, your visceral fat may naturally decrease even if your weight and muscle mass stay the same. This highlights the importance of monitoring visceral fat, not just weight.

Genotype-based dietary interventions (low-carb vs. low-fat) do not significantly impact weight loss outcomes, suggesting that genotyping alone is not an effective precision medicine approach for weight loss.

Don't pay for expensive genetic testing to tell you whether to eat low-carb or low-fat. Current high-quality evidence shows that your genotype does not predict whether you will lose more weight on one diet versus the other. Focus on finding a dietary pattern you can adhere to consistently that creates a caloric deficit.

Sarcopenia is driven by anabolic resistance, mitochondrial dysfunction, and chronic inflammation, which decouple muscle mass from muscle function.

Understanding that muscle mass and function are different helps explain why you might look stronger but still feel weak. Treating the underlying inflammation and mitochondrial health is as important as building size.

The evolution of human fat storage levels is driven by a trade-off between starvation risk and predation risk, resulting in an optimum fatness that minimizes total mortality, not maximum fat storage.

Your body stores fat to balance survival needs (starvation) against survival costs (predation/mobility). This explains why we don't store maximum possible fat; there is an evolutionary optimum.

Patients with higher comorbidity burdens (cardiovascular risk, respiratory, pain, mental health) and higher BMI are significantly more likely to receive high-intensity interventions (surgery/procedures) rather than lifestyle intervention, while anti-obesity medications (AOMs) are underutilized relative to guidelines.

If you have obesity and comorbidities like diabetes or heart disease, you are more likely to get surgery or procedures than medication or lifestyle programs, even if guidelines suggest medication first. This is because providers often wait for severe BMI or complications before escalating care. You should discuss all options, including AOMs, with your provider rather than waiting for surgery eligibility.

In patients with Obstructive Sleep Apnea (OSA) treated with CPAP, a history of prior vascular events, hypertension, older age at treatment initiation, and higher comorbidity burden are significant independent risk factors for subsequent vascular events, whereas obesity (BMI) is not.

If you have OSA and use CPAP, adherence is crucial, but it does not guarantee immunity from heart issues. Your risk of a vascular event is significantly higher if you have high blood pressure, a history of heart problems, or other chronic conditions. Focus on managing your blood pressure and comorbidities alongside your CPAP therapy, and seek early diagnosis and treatment to mitigate age-related risks.

Vegan diets do not significantly affect blood pressure, HDL-C, or triglycerides compared to control diets in individuals with overweight or type 2 diabetes.

Do not expect a vegan diet to automatically lower your blood pressure or triglycerides if they are currently normal or if the diet is not carefully managed. The primary benefits observed were weight loss, improved HbA1c, and reduced LDL cholesterol. Monitor your BP and triglycerides separately.

Caloric restriction (CR) is an effective intervention that impacts aging, age-related pathologies, and longevity in model organisms such as mice and rats.

While this paper confirms caloric restriction extends longevity in mice and rats, it does not provide specific human dosing protocols. For humans, this suggests that avoiding overconsumption and maintaining a healthy weight may support healthy aging, but specific restriction protocols should be discussed with a healthcare provider.

Epigenetic clocks, such as the DNAm PhenoAge and DunedinPoAm, can predict biological age, lifespan, and risk of chronic disease.

Epigenetic clocks are emerging tools to measure biological aging. While not yet standard clinical practice, they may eventually help individuals track the impact of lifestyle changes on their biological age.

Specific gut microbiota species and their metabolites (SCFAs, bile acids) actively maintain intestinal barrier integrity and exert anti-inflammatory effects.

Consuming a diet rich in diverse fibers supports the growth of beneficial bacteria that produce SCFAs and strengthen the gut barrier. This is a key strategy for reducing systemic inflammation and supporting metabolic health.

The SenMayo gene set (125 genes) accurately identifies senescent cells across tissues and species, and its expression levels significantly decrease following genetic or pharmacological clearance of senescent cells, serving as a reliable biomarker for senolytic efficacy.

SenMayo is a validated 125-gene signature that can detect senescent cells in various tissues (bone, brain, fat) and track their reduction after senolytic treatments (like Dasatinib + Quercetin). It is currently a research tool for monitoring senolytic efficacy, not a standard clinical test yet.

Epigenetic clocks based on DNA methylation levels can predict chronological age and the risk of aging-related diseases.

Epigenetic clocks can measure biological age. This can help assess the efficacy of aging interventions.

Pharmacological elimination of senescent cells (senolytics) or suppression of their secretory phenotype (senomorphics) delays or alleviates multiple age-related pathologies and extends healthspan in animal models.

Current research suggests that clearing senescent cells may help delay age-related diseases. However, effective treatments are still in clinical trials. Do not attempt to self-medicate with unproven supplements claiming to be 'senolytics' without medical supervision, as efficacy and safety are not yet established for general use.